|



Key: Meeting
Journal
Funder

Showing releases 1-25 out of 3154. 1 | 2 | 3 | 4 | 5 > >>

Public Release: 2-Dec-2012
 Nature Chemical Biology
Glowing fish shed light on metabolism
A tiny, translucent zebrafish that glows green when its liver makes glucose has helped an international team of researchers identify a compound that regulates whole-body metabolism and appears to protect obese mice from signs of metabolic disorders.

National Institutes of Health and by a grant from the American Heart Association
Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Public Release: 2-Dec-2012
 Nature Genetics
Cell surface transporters exploited for cancer drug delivery
According to Whitehead Institute researchers, a protein known as monocarboxylate transporter 1 (MCT1), which is highly expressed in a subset of metabolically altered cancer cells, is needed for the entry of the investigational cancer drug 3-bromopyruvate (3-BrPA) into malignant cells. This work may open a new avenue for cancer therapeutic research, as other transport molecules have already been identified on the surface of certain cancer cells.

National Institutes of Health, David H. Koch Institute for Integrative Cancer Research, Jane Coffin Childs Fund, National Science Foundation
Contact: Nicole Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
Public Release: 2-Dec-2012
 Nature Genetics
Scientists find 'bully' genes in common childhood tumor
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.

St. Baldrick's Foundation, NIH/National Cancer Institute
Contact: Vanessa Wasta
wasta@jhmi.edu
410-614-2916
Johns Hopkins Medicine
Public Release: 2-Dec-2012
 Nature Structural & Molecular Biology
Scientists at Scripps Research Institute discover how 2 proteins help keep cells healthy
Scientists at The Scripps Research Institute have determined how two proteins help create organelles, or specialized subunits within a cell, that play a vital role in maintaining cell health. This discovery opens the door for research on substances that could interfere with the formation of these organelles and lead to new therapies for cancer.

National Institutes of Health, Japan Science and Technology Agency
Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Public Release: 2-Dec-2012
 Nature Genetics
Genes linked to low birth weight, adult shortness and later diabetes risk
An international team of genetics researchers has discovered four new gene regions that contribute to low birth weight. Three of those regions influence adult metabolism, and appear to affect longer-term outcomes such as adult height, risk of type 2 diabetes and adult blood pressure. The cumulative effect of the genes is equivalent to the effect of maternal smoking during pregnancy.

National Institutes of Health, Wellcome Trust, Medical Research Council, and others
Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Public Release: 2-Dec-2012
 Nature Genetics
New gene-sequencing tools offer clues to highest-risk form of a childhood cancer
Using powerful gene-analysis tools, researchers have discovered mutations in two related genes, ARID1A and ARID1B, that are involved in the most aggressive form of the childhood cancer neuroblastoma. While these findings do not immediately improve clinical treatments, they identify a novel pathway that is defective in these cancers, a pathway that scientists can now study to develop potential new therapies.

St. Baldrick's Foundation, National Institutes of Health, Children's Oncology Group, and others
Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-426-6063
Children's Hospital of Philadelphia
Public Release: 1-Dec-2012
 Journal of Thoracic Oncology
Lung cancer patients with pockets of resistance prolong disease control by 'weeding the garden'
This study of 65 patients showed that continuing either crizotinib or erlotinib after the treatment of resistant pockets with focused radiation ("weeding the garden") was associated with more than half a year of additional cancer control.

NIH/National Cancer Institute
Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Public Release: 30-Nov-2012
 NeuroImage
In schizophrenia patients, auditory cues sound bigger problems
Researchers at the University of California, San Diego School of Medicine and the VA San Diego Healthcare System have found that deficiencies in the neural processing of simple auditory tones can evolve into a cascade of dysfunctional information processing across wide swaths of the brain in patients with schizophrenia.

NIH/National Institute of Mental Health, US Department of Veteran Affairs, Mitsubishi Pharma Research
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Public Release: 30-Nov-2012
 Lancet
Emerging vector-borne diseases create new public health challenges
West Nile virus, Lyme disease, dengue fever, and plague are examples of "vector-borne zoonotic diseases," caused by pathogens that naturally infect wildlife and are transmitted to humans by vectors such as mosquitoes or ticks. Land-use change, globalization of trade and travel, and social upheaval are driving the emergence of such diseases in many regions.

National Science Foundation, National Institutes of Health
Contact: Tim Stephens
stephens@ucsc.edu
831-459-2495
University of California - Santa Cruz
Public Release: 30-Nov-2012
 Genetics
Native Americans and Northern Europeans more closely related than previously thought
Using genetic analysis, scientists have discovered that Northern European populations descend from a mixture of two very different ancestral populations, and one of these populations is related to Native Americans. This discovery helps fill gaps in scientific understanding of both Native American and Northern European ancestry, while providing an explanation for some genetic similarities among what would otherwise seem to be very divergent groups.

National Science Foundation, National Institutes of Health
Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-634-7302
Genetics Society of America
Public Release: 30-Nov-2012
 PLOS One
Researchers discover how C. diff red lines immune response
Virginia Tech researchers have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection. Using computational and mathematical modeling in combination with RNA-sequencing and mouse studies, scientists examined an important regulatory pathway during Clostridium difficile infection. They found the severity of the C. difficile infection can be reduced by using an existing diabetes drug. More studies are needed before the drug can be tested in patients.

NIH/National Institute of Allergy and Infectious Diseases
Contact: Tiffany Trent
ttrent@vt.edu
540-231-6822
Virginia Tech
Public Release: 30-Nov-2012
 PLOS ONE
Electrically spun fabric offers dual defense against pregnancy, HIV
Electrically spun cloth with nanometer-sized fibers show promise as a cheap, versatile platform to simultaneously offer contraception and prevent HIV. New funding from the Bill & Melinda Gates Foundation will further test the system's versatility and feasibility.

National Institutes of Health, Bill & Melinda Gates Foundation
Contact: Hannah Hickey
hickeyh@uw.edu
206-543-2580
University of Washington
Public Release: 29-Nov-2012
 Tobacco Control
As cigarette taxes go up, heavy smoking goes down
When cigarette taxes rise, hard-core smokers are more likely than lighter smokers to cut back, according to new research from Washington University School of Medicine in St. Louis.

National Center for Research Resources, National Institute on Drug Abuse, NIH/Roadmap for Medical Research
Contact: Judy Martin
martinju@wustl.edu
314-286-0105
Washington University School of Medicine
Public Release: 29-Nov-2012
 Journal of the Neurological Sciences
Promising drug slows down advance of Parkinson's disease and improves symptoms
Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study published online Nov. 28 in the Journal of the Neurological Sciences.

National Institutes of Health
Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Public Release: 29-Nov-2012
 Nature Communications
Gladstone scientists identify key biological mechanism in multiple sclerosis
Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis -- a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord. This discovery offers new hope for the millions who suffer from this debilitating disease for which there is no cure.

National Multiple Sclerosis Society, American Heart Association, Howard Hughes Medical Institute, National Institutes of Health, Nancy Davis Foundation, Dana Program, H. Lundbeck A/S
Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes
Public Release: 29-Nov-2012
 Journal of Biological Chemistry
Activating ALC1: With a little help from friends
Chromatin remodeling -- the packaging and unpackaging of genomic DNA and its associated proteins -- regulates a host of fundamental cellular processes including gene transcription, DNA repair, programmed cell death as well as cell fate. In their latest study, scientists at the Stowers Institute for Medical Research are continuing to unravel the finicky details of how these architectural alterations are controlled.

NIH/National Institute of General Medical Sciences, Helen Nelson Medical Research Fund
Contact: Gina Kirchweger
gxk@stowers.org
816-806-1036
Stowers Institute for Medical Research
Public Release: 29-Nov-2012
New grant funds autism research at SDSU
San Diego State University psychology research professor Inna Fishman is embarking on a study to identify the differences in brain networks of children and adolescents with autism and those who are typically developing.

NIH/National Institute of Mental Health
Contact: Natalia Van Stralen
Natalia.vanstralen@sdsu.edu
619-594-2585
San Diego State University
Public Release: 29-Nov-2012
 Population Health Management
Diabetics with cancer dangerously ignore blood sugar
When people with Type 2 diabetes are diagnosed with cancer -- for which they are at higher risk -- they ignore their diabetes to focus on cancer. But high blood sugar is more likely to kill them. When they received diabetes education after a cancer diagnosis, however, they were more likely to monitor their blood sugar and had fewer visits to the emergency room, fewer hospital admissions and lower health care costs.

NIH/National Cancer Institute
Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University
Public Release: 29-Nov-2012
Adolescent girls focus of New University of Houston study
As a young clinical social worker, Danielle Parrish, an assistant professor at the University of Houston Graduate College of Social Work, frequently noticed that at least a third of the girls were visibly pregnant on the girl's unit in a juvenile detention center.

National Institutes of Health
Contact: Melissa Carroll
mcarroll@uh.edu
713-743-8153
University of Houston
Public Release: 29-Nov-2012
 Advanced Materials
Precisely engineering 3-D brain tissues
Borrowing from microfabrication techniques used in the semiconductor industry, MIT and Harvard Medical School engineers have developed a simple and inexpensive way to create three-dimensional brain tissues in a lab dish.

National Science Foundation, Paul Allen Family Foundation, NY Stem Cell Foundation, National Institutes of Health, IET A F Harvey Prize, Massachusetts Institute of Technology Lincoln Lab
Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology
Public Release: 29-Nov-2012
 Proceedings of the National Academy of Sciences
Bacteria hijack host cell process, create their own food supply to become infectious
Bacteria that cause the tick-borne disease anaplasmosis in humans create their own food supply by hijacking a process in host cells that normally should help kill the pathogenic bugs, scientists have found.

National Institutes of Health
Contact: Yasuko Rikihisa
Rikihisa.1@osu.edu
614-292-9677
Ohio State University
Public Release: 29-Nov-2012
 Cell Reports
Enzyme inhibition protects against Huntington's disease damage in 2 animal models
Treatment with a novel agent that inhibits the activity of SIRT2, an enzyme that regulates many important cellular functions, reduced neurological damage, slowed the loss of motor function and extended survival in two animal models of Huntington's disease.

National Institutes of Health
Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Public Release: 29-Nov-2012
 Cancer Cell
Study sheds light on how pancreatic cancer begins
Research led by scientists at the University of California, San Diego and UC San Francisco Schools of Medicine examined the tumor-initiating events leading to pancreatic cancer (also called pancreatic ductal adenocarcinoma or PDA) in mice. Their work, published on line November 29 in the journal Cancer Cell, may help in the search for earlier detection methods and treatments.

National Institutes of Health
Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Public Release: 29-Nov-2012
 PLOS Genetics
Genome-scale study identifies hundreds of potential drug targets for Huntington's disease
Scientists seeking to develop treatments for Huntington's disease just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNAi technology to identify hundreds of "druggable" molecular targets linked to the toxicity associated with HD. The gene RRAS, involved in cell motility and neuronal development, was among the diverse range of modifiers identified. RRAS was revealed as a potent modulator of HD toxicity in multiple HD models.

National Institutes of Health, CHDI Foundation, Hereditary Disease Foundation
Contact: Kris Rebillot
krebillot@buckinstitute.org
415-209-2080
Buck Institute for Age Research
Public Release: 29-Nov-2012
 Cancer Cell
Study helps resolve debate about how tumors spread
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors.

American Cancer Society, National Institutes of Health, Sidney Kimmel Foundation for Cancer
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Showing releases 1-25 out of 3154. 1 | 2 | 3 | 4 | 5 > >>

|